Dr. Carlton Robert Fenzl, MD

Dr. Fenzl practices at Spring Park Surgery Center in Davenport, Iowa.

Dr. Fenzl's NPI, 1386958064, was assigned on August 4, 2010. Dr. Fenzl holds Iowa license 42474.

Dr. Fenzl's primary practice is Spring Park Surgery Center, at 3319 Spring Street, Davenport, IA 52807. The practice phone is (563) 355-6236.

Dr. Fenzl's primary practice is Spring Park Surgery Center in Davenport, Iowa. Dr. Fenzl is also affiliated with Hammond-Henry Hospital. Dmand AI also links Dr. Fenzl to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fenzl practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Fenzl's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Fenzl's licenses on file in 2 states: Iowa and Illinois.

CMS data shows 11,998 Medicare services from Dr. Fenzl across 22 procedure codes in 2024, for 734 Medicare patients. Medicare paid $941,780 for them.

CMS counts 734 Medicare patients who saw Dr. Fenzl in 2024. The largest group is 75 to 84, with 324 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fenzl's median patient age at 74, with 57% women.

In 2024, Dr. Fenzl wrote 3,212 Medicare Part D claims for 896 patients. 51% of them were for generic drugs. CMS names the drug for 3,131 of them, across 22 drugs with 11 or more claims each, at $262,546 in total drug cost. In 2023, CMS named 2,806 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Fenzl for performance year 2024, reported as part of a group. Dr. Fenzl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 685 procedures of cataract surgery by Dr. Fenzl, more than 97% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Fenzl, published from 2014 to 2017. 2014 was the busiest year, with 3. The most frequent topics are Keratomileusis, Laser In Situ, Visual Acuity and Corneal Diseases. Dr. Fenzl has published most often in Clin Ophthalmol. Dr. Fenzl's most frequent co-authors are Mark David Mifflin, MD, Ladan Espandar, MD and Adam John Gess, MD.

CMS Open Payments shows 197 general payments to Dr. Fenzl from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. RxSight Inc paid the most, $3,837.